Min Li, N/A

RemeGen Co., Ltd., China (People's Republic)

Poster(s):

• PI-028 - CLINICAL PHARMACOKINETICS AND BIOMARKER ANALYSES OF RC88, A NEW MESOTHELIN-TARGETING ANTIBODY DRUG CONJUGATE, IN PATIENTS WITH ADVANCED SOLID TUMORS
  Wednesday, May 28, 2025

  5:00 PM - 6:30 PM East Coast USA Time